Study links HHV-6 reactivation to increasingly poor outcome following myeloablative HSCT
HHV-6 reactivation tied to increased mortality and acute GVHD in HSCT
HHV-6 detection associated with increasingly poor outcome for stem cell transplant patients.
HHV-6 Reactivation linked to complications in Allogenic Stem Cell Transplantation
Researchers have tied HHV-6 Reactivation to GVHD, seizures, pneumonia, and encephalitis in Allo-SCT patients.